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Abstract Most evidence for a key role of calcium entry Key words Ischaemia • Calcium channel blocker * 
in hypoxia-induced renal damage stems from studies potassium channels 
with calcium channel blockers. In proximal tubules, a 
primary site of renal ischaemic injury, only phenyl- 
alkylamines, especially verapamil, have been studied.
In the present study the effect of the dihydropyridine 
felodipine on hypoxic injury in isolated rat proximal 
tubules was investigated. To discriminate between the 
block of calcium entry and other effects, the enan- 
tiomers and a non-calcium blocking derivative of 
felodipine (H I86/86) were included. Cell membrane 
injury was assessed by measuring the release of lactate 
dehydrogenase (LDH). At high concentrations 
(100 jiM) felodipine, HI86/86 and the two enantiomers 
all protected rat proximal tubules against hypoxia- 
induced injury to the same extent. Absence of extra­
cellular calcium did not offer protection, but rather 
enhanced hypoxic injury. All dihydropyridines used 
increased the intracellular potassium concentration 
during normoxia. Felodipine attenuated the hypoxia- 
induced loss of cellular potassium. We have tried to 
mimic the effects of felodipine by using potassium chan­
nel blockers. The potassium channel blockers quinidine 
and glibenclamide afforded some protection against 
hypoxic injury, although their effects on cellular potas­
sium were equivocal. We conclude that the dihydropy­
ridine calcium channel blocker felodipine protects 
rat proximal tubules against hypoxic injury via a cal­
cium-independent mechanism. We propose that high 
levels of intracellular potassium and attenuation of 
potassium loss during hypoxia are important in this 
protection.
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Introduction
The role of calcium in hypoxic renal injury is still a 
matter of dispute. Most evidence in favour of a role for 
calcium stems from experiments with calcium channel 
blockers (CCBs). Indeed, it has been demonstrated that 
CCBs afford protection in models of in vivo ischaemic 
renal injury [2, 4, 23, 25, 29]. However, protection in 
these models could be ascribed to the well-known 
vasodilatory and diuretic properties of CCBs [29]. To 
evaluate direct protective effects of CCBs on renal tubu­
lar epithelium, studies have been performed in in vitro 
models of ischaemic renal injury, using freshly isolated 
renal tubules or renal cell cultures. In these model sys­
tems CCBs of the phenylalkylamine class have been 
studied and proven effective. Verapamil protected iso­
lated rat proximal tubules against hypoxia [30] and 
methoxyverapamil afforded partial protection against 
anoxic injury in rabbit proximal tubular cells [22].
At present it is unknown whether CCBs of other 
classes are able to attenuate hypoxic cell injury. In addi­
tion, it has not been proven that phenylalkylamines 
exert their protective effects via inhibition of calcium 
influx. The concentration of verapamil needed to pro­
tect rat proximal tubules from hypoxic injury was rel­
atively high (100 |llM )  and protection was independent 
of the presence of extracellular calcium [30]. CCBs 
could offer protection by a variety of mechanisms. They 
not only show vasodilatory properties [6], but at high 
concentrations they also interact with sodium and 
potassium channels [3, 8, 9, 10, 20, 27] and some could 
act as antiperoxidants [13].
We have studied the effects of the dihydropyridine 
felodipine on hypoxic injury in isolated rat proximal 
tubules. In order to discriminate between calcium entry 
inhibition and other effects of felodipine, a non-
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calcium blocking felodipine derivative and the felodi­
pine stereoisomers were included in our study. 
Felodipine indeed protects rat proximal tubules against 
hypoxia-induced plasma membrane injury. Although 
this finding seems to support a role for calcium in 
hypoxia-induced injury, we present evidence that the 
protection by felodipine is not due to a blockade of 
calcium influx, but might be related to effects on potas­
sium channels resulting in attenuation of potassium 
efflux during hypoxia.
Low-calcium experiments
In several experiments we have studied the effect of low-calcium 
medium on hypoxic injury. For these low-calcium experiments, wc 
followed the standard procedure for isolation and purification of 
the tubules. After the initial period of warming, llie proximal tubules 
were washed twice with nominally calcium-free buffer and subse­
quently resuspended in this same buffer (final calcium concentra­
tion approximately 10 jiM) [22]. Control flasks were supplemented 
with 1 mM CaCl2.
Stock solutions
Materials and methods
Isolation of rat proximal tubules
Proximal tubules were isolated from kidney cortex of male Sprague- 
Dawley rats weighing 200-300 g by collagenase digestion 
(Collagenase A, Boehringer Mannheim, Almere, The Netherlands) 
and centrifugation on a Percoll (Pharmacia, Wocrden, The 
Netherlands) gradient as described by Wetzels et al. [30], Between 
the period of incubation in collagenase and the centrifugation step, 
cortex tissue was suspended in buffer supplemented with 1% albu­
min (Albumin Fraction V fatty acid free, Boehringer Mannheim) 
for approximately 15 min. Purified tubules were suspended in a 
modified Krebs-Henscleit buffer of pH 7.3, gassed with 
95% 02/5 % C 0 2, containing (in mM): D-glucose 5; MgS04 1; NaCl 
1D6; NaHCOj 20; KC1 5; NaH.PO., 2; 4-(2-hydroxyethyl)-l-piper- 
azinccthancsulphonic acid (HEPES) 10; CaCI2 1; L-glutamine 2; n- 
bulyric acid 10; L-lactic acid 4. The suspension, containing typically
1.5-3.0 mg protein/ml, was gassed with 95% 03/5% C 02 for 5 min 
on ice and then warmed up gradually (10 min at room tempera­
ture, 10 min al 37° C). Aliquots of 5-7 ml were put in siliconized 
(Sigmacotc, Sigma, Axel, The Netherlands) Erlenmeyer flasks 
(25 ml) and protective compounds or the appropriate vehicles were 
added. The experiment was started by gassing individual flasks with 
either 95 % 02/ 5 % C02 (normoxia) or 95%N2/5%C02 (hypoxia) in 
a shaking waterbath at 37° C. After 5 min, the flasks were sealed.
Potassium and lactate dehydrogenase assays
Samples for the assessment of cell membrane injury and for the 
determination of intracellular potassium contents were taken after 
15 and 30 min of incubation. Cell membrane injury was assessed 
by release of lactate dehydrogenase (LDH) [30]. Increased release 
of LDH indicates complete loss of cell membrane integrity, and 
reflects irreversible injury. LDH activity in the supernatant was 
expressed as a percentage of total LDH activity. To determine intra­
cellular potassium levels, samples were centrifuged through 700 j.il 
of L-bromododecane (Aldrich, Axel, The Netherlands) into 200j.il 
of sucrose/Ficoll (270 mM sucrose, 4% Ficoll 400, Pharmacia, 
Woerden, The Netherlands) and further processed for atomic 
absorption spectroscopy [30], Potassium concentrations are 
expressed in nmoles per milligram protein. Protein was quantified 
by the method developed by Lowry el al. [16]. When using this 
methodology for the measurement of intracellular potassium, it 
must be remembered that severely damaged tubules do not pass 
through the oil layer. Therefore, injury is reflected by a low recov­
ery of protein in the sucrose/Ficoll pellet. After 30 min of hypoxic 
incubation, hardly any pro Lein passes through the oil into the 
sucrose/Ficoll layer. When the amount of protein recovered in the 
pellet is low (i.e. < 0.2 mg/ml), the results of the potassium meas­
urements are no longer reliable.
Concentrated stock solutions (100 mM) of felodipine (Astra Hässle, 
Mölndal, Sweden), its non-calcium blocking derivative H I86/86 
(Astra Hässle) and the felodipine isomers (Astra Hässle) were stored 
maximally for 1 month at room temperature and shielded from 
light. Stock solutions were prepared in PEG400 according to the 
instructions of the Astra company. Final concentrations of PEG400 
were routinely 0.1% v/v and never exceeded 1% v/v. All vehicles 
were tested for their influence on LDH release and intracellular 
potassium concentration. The potassium channel blockers were 
added from concentrated stocks: 100 mM quinidine HC1 in 
PEG400, 1 M quinine sulphate (Fluka, Buchs, Switzerland) in a 
mixture of 2 parts chloroform and 1 part ethanol, 10 mM and 
500 mM glibcnclamide in dimethylsulphoxide (DMSO). 
Appropriate controls were routinely assayed.
Materials
All chemicals were of the purest grade and obtained from Sigma 
(Axel, The Netherlands) or Merck (Amsterdam, The Netherlands) 
unless otherwise indicated.
Statistical analysis
All reported data are expressed as means ± SEM. Statistical 
analysis was performed using analysis of variance (ANOVA) 
and comparisons between groups were done using Student- 
Newman-Keuls tests using the INSTAT software (Graphpad, 
San Diego, Calif., USA). A P value below 0.05 is considered 
significant.
Results
LDH release and intracellular potassium content 
during normoxia and hypoxia
In our preparation of isolated tubules, LDH release 
amounted to 14 ± 3% after the initial period of war­
ming (t =  0). During normoxic incubations LDH 
release increased further to 24 ± 2% after 30 min. 
Hypoxic incubation of the tubules resulted in a marked 
increase in LDH release (Fig. 1), Intracellular potas­
sium levels remained stable during normoxic incuba­
tion but decreased during one which was hypoxic 
(Table 1). After 30 min of hypoxia, measurements of 
intracellular potassium were no longer reliable, since 
only a small amount of tubules had survived.
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Fig. 1 Effects of felodipine on normoxic and hypoxic cell injury. 
Cell injury as reflected by the percentage of lactate dehydrogenase 
(LDH) released from rat proximal tubules during normoxic (open 
squares) or hypoxic [open circle) incubation and effects of 100 juM 
felodipine on hypoxia (filled circles) and normoxia (filled squares). 
Data are shown as means ± SEM of 6 to 8 experiments. Asterisks 
depict significant differences from values under similar conditions 
in the absence of felodipine. < 0.05, **P < 0.001
ao
W W 4
o
a(X
<D
%
a
80a,
80 -
60 -
40 I
20 -
0
15 30
Time (min)
Fig. 2 Percentage protection against hypoxic cell injury in rat proxi­
mal tubules by felodipine (striped bars) and its derivative H I86/86 
(filled bars) compared to hypoxic values (100% protection would 
be the normoxic control value). Data are shown as means ± SEM 
of at least 7 experiments. Both felodipine and H I86/86 offer 
significant protection at 30 min of hypoxia. At 15 min, H186/86 is 
less effective than felodipine. *P < 0.01
Effects o f felodipine
Felodipine (100 pM) protected isolated proximal tubules 
during 15 and 30 min of hypoxia, as assessed by the per­
centage of LDH release (Fig. 1). A lower concentration 
of felodipine (10 jaM) did not protect the tubules (LDH 
release 38 ± 3% vs 44 ± 3% and 68 ± 2% vs 72 ± 3% 
for hypoxic control vs in the presence of 10 \xM felodi­
pine after 15 and 30 min respectively). Under normoxic 
conditions 100 jiM felodipine caused some tubular 
damage as assessed by LDH release (Fig. 1).
Effect of low extracellular calcium
Isolated proximal tubules were incubated in media 
devoid of added calcium and free calcium levels in these 
solutions were estimated to be approximately 10 jliM 
[22]. Removal of extracellular calcium resulted in a 
decrease of intracellular potassium under normoxic 
conditions and was deleterious to renal tubules under 
hypoxic conditions (Table 1). The protective effect of 
felodipine was still observed in the absence of extra­
cellular calcium (Table 1).
Table 1 Effects of low extracellular calcium on lactate dehydroge­
nase (LDH) release and intracellular potassium content during nor- 
moxia and hypoxia. (Norm Normoxia, Hyp Hypoxia). Tubules were 
washed and incubated in nominally calcium free medium contain­
ing approximately 10 pM Ca2+ (see Materials and methods). 
Normoxic and hypoxic controls were supplemented with extra cal­
cium before incubation to a final concentration of 1 mM. Felodipine 
100 pM was added after washing. After 30 min of hypoxia with or 
without calcium, potassium measurements were no longer reliable 
(see Materials and methods). Data are expressed as means ± SEM. 
Number of experiments (n) is given for each condition
Incubation period 
15 min 30 min
Conditions LDH
(%)
K+
(nmol/mg)
LDH
(%)
K +
(nmol/mg)
n
Norm 18 ± 1 215 ± 6 27 ± 2 200 ± 9 21
Norm/low Ca2+ 22 ± 2 159 ± 9* 29 ± 4 164 ±7* 14
Hyp 38 ± 3* 100 ± 6* 68 ±2* — 16
Hyp/low Ca2+ 59 ± 6** 63 ± 5** 78 ± 4 — 7
Hyp/low Ca2+ 
+ felodipine
46 ± 5*** 102 ±9*** 45 ± 6**** 77 ± 8 7
*P < 0.001 compared to normoxia,**P < 0.01 compared to hypoxia, ***ƒ> < 0.05 compared to hypoxia/low Ca2+, ****ƒ> < 0.001 comp' 
ared to hypoxia/low Ca2+
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Fig. 3 Rat proximal tubules incubated under normoxic (open 
squares) and hypoxic { filled circles) conditions for 30 min. Hypoxic 
tubules were also incubated with the stereoisomers of felodipine, 
which were added just before the period of the hypoxic incubation. 
Open circles represent felodipine —, filied squares felodipine-h Data 
are expressed as means ± SEM of at least 6 experiments. Asterisks 
depict significant differences with hypoxic values. < 0.001
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Fig. 5 Intracellular potassium content measured after 15 min of 
incubation under normoxic and hypoxic conditions. Striped bars 
represent the control values without additions. Felodipine and its 
stereoisomers are represented in the other bars: racemic mixture 
(dotted bars), felodipine + ( filled bars) and felodipine — (open bars). 
Data are given as means ± SEM of at least 7 experiments. *P < 0.05, 
**P < 0.01 compared to the respective normoxic or hypoxic con­
trol values
(F+) does not block L-type calcium channels. Both iso­
mers afforded protection against hypoxia as assessed 
by LDH release (Fig. 3).
The non-calcium blocking felodipine derivative 
H I86/86 also decreased LDH release during hypoxia, 
although the effect was less pronounced than with 
felodipine and became more marked after 30 min of 
incubation (Fig. 2). Since the commercially available 
felodipine is a racemic mixture of two stereoisomers, 
we also tested the individual compounds in the same 
experimental settings. Felodipine- (F —) is the phar­
macologically active compound, whereas felodipine+
Fig. 4 Intracellular potassium content of rat proximal tubules dur­
ing normoxic incubation (open bars) and the effect of 100 (.iM 
felodipine [stripedbars) and 100 jliM H I86/86 {filledbars) on potas­
sium levels after 15 and 30 min of incubation. Data are shown as 
means ± SEM of at least 5 experiments, *P<0.05, **P<0.01 
compared to normoxic potassium levels
Effects of dihydropyridines on potassium levels
We observed a significant increase in intracellular 
potassium levels during normoxic incubation of the 
proximal tubules with either felodipine or its deriva­
tive (Fig. 4). During hypoxia felodipine significantly 
preserved potassium levels after 15 min of incubation 
(Fig. 5). Both stereoisomers were equally effective in 
increasing intracellular potassium levels (Fig. 5). In 
contrast, the felodipine derivative H I86/86 did not 
significantly preserve potassium levels during hypoxia 
(data not shown).
Effects of potassium channel blockers
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We studied the effects of the potassium channel block­
ers quinine (1 mM), quinidine (1 mM) and gliben- 
clamide (10 jiM and 500 (iM) under normoxic and 
hypoxic conditions. Quinine and quinidine increased 
intracellular potassium levels under normoxic condi­
tions, but did not prevent the loss of potassium dur­
ing hypoxia (Table 2). Quinidine but not quinine 
attenuated cellular injury, as reflected by the level of 
LDH release after 30 min (Table 2). Both blockers 
increased cell injury after 15 min of normoxic incuba­
tion. The damaging effect of quinidine became more 
marked after 30 min (Table 2). Glibenclamide 
(500 |uM) preserved cell membrane integrity, as 
assessed by LDH release during 30 min of hypoxia 
(Fig. 6). Intracellular potassium levels during hypoxia
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'Fable 2 Elïect of potassium channel blockers on LDH release and 
potassium content. Tubules were incubated in medium with or with­
out 1 mM quinine or quinidine under normoxic or hypoxic condi­
tions. After 15 and 30 min the percentage LDH released in the
medium and the amount of intracellular potassium per mg protein 
were determined (see Materials and methods). Data are shown as 
means ± SEM. The number of experiments (n) is included for each 
condition
Conditions
Incubation period 
15 min 30 min
nLDH
(%)
K+
(nmol/mg)
LDH
(%)
K+
(nmol/mg)
N o rm 13 ± 1 268 ± 12 19 ± 2 254 ± 14 13
Norm /quinine 21 ± 2** 336 ± 13** 25 ± 4 346 ±11* 7
Norm/quinidine 34 ± 5* 336 ± 35** 40 ± 7* 306 ± 27** 6
Hyp 30 ± 3* 132 ± 18* 59 ± 6* 103 ±23* 7
Hyp/quinine 27 ±2 118 ± 10 56 ± 3 76 ± 6 6
Hyp/quinidine 25 ±3 107 ± 18 40 ± 3*** 74 ± 10 6
*P < 0.01 compared to normoxia, '**P < 0.05 compared to normoxia, ***P < 0.05 compared to hypoxia
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Fig. 6 Cell injury as reflected by the percentage of LDH released 
from rat proximal tubules during normoxic (open squares) or 
hypoxic {open circle) incubation and the effect of 500 j.iM gliben- 
clamide on normoxic {closed squares) and hypoxic (closed circles) 
tubules. Data are given as means ± SEM of at least 5 experiments. 
*P<0.01 compared to the appropriate normoxic or hypoxic 
controls
were not influenced by glibenclamide (146 ±
21 nmol/mg protein vs 131 ± 23 nmol/mg protein for 
hypoxic control vs in the presence of 500 jiM gliben­
clamide after 30 min). During normoxia, the 
presence of glibenclamide resulted in an increased LDH 
release (Fig. 6) and decreased intracellular potassium 
levels (261 ± 12 nmol/mg protein vs 179 ± 33 nmol/mg 
protein for normoxic control vs in the presence of 
500 (llM  glibenclamide after 30 min). A lower concen­
tration of glibenclamide (10 \xM) did not have an effect 
on normoxic or hypoxic LDH release or on potassium 
levels (data not shown).
Discussion
The role of intracellular calcium in hypoxia-induced 
renal damage is still a matter of debate. Most evidence
in favour of a role for calcium is based upon experi­
ments with CCBs. Specifically, CCBs of the phenyl- 
alkylamine class have been demonstrated to protect 
renal tissue against oxygen deprivation injury both in 
vivo [23, 29] and in vitro [1, 22, 24, 30]. Certainly, the 
protective efficacy of the phenylalkylamine verapamil 
provides only indirect and weak evidence for a role of 
calcium in hypoxic renal injury. The development of 
single cell fluorescence imaging techniques has allowed 
direct measurements of intracellular calcium concen­
trations. Recent studies have shown that intracellular 
calcium increases during hypoxia in freshly isolated rat 
proximal tubules [15] and in isolated rabbit proximal 
tubule cells [22], and a relationship between the increase 
of intracellular calcium and the occurrence of cell 
injury was suggested [15]. Although these studies point 
to a role for calcium in hypoxic injury, they do not 
unequivocally demonstrate that verapamil protects 
renal tubular cells by blocking calcium influx. Some 
investigators suggest that protection is independent of 
the calcium blocking properties of the drugs [1, 30], 
Indeed, it has been demonstrated that relatively high 
concentrations of verapamil (100 |liM )  are required for 
protection [1, 30]. It was also shown that verapamil was 
protective in the absence of extracellular calcium [30].
Our present study with dihydropyridines demon­
strates clearly that felodipine also protects isolated rat 
proximal tubules against hypoxia-induced plasma 
membrane injury as assessed by LDH release. Our data 
are in close agreement with the reported effects of vera­
pamil. Although this may suggest a role Tor calcium in 
oxygen deprivation injury, we present four lines of evi­
dence that protection by felodipine is not due to a 
blockade of calcium influx.
First, felodipine only protects rat proximal tubules 
against hypoxia-induced injury at high concentrations 
(100 (J.M). Binding of dihydropyridine-type CCBs to L- 
type Ca2+ channels, as characterized in cardiac tissue 
[6] and in depolarized smooth muscle cells [31], occurs, 
however, at nanomolar concentrations. Still, it is pos­
sible that calcium channels present in rat proximal
tubules can only be blocked at high concentrations. 
Different concentrations of dihydropyridines are 
reported to block L-type calcium channels in cardiac 
tissue (nanomolar range) and skeletal muscle (micro­
molar range) [6]. Also, binding of dihydropyridines to 
their receptor depends on factors varying between tis­
sues and experimental conditions, such as membrane 
potential and the state of the channel (resting or inac­
tivated) [6, 11, 14, 31], Recently, Matsunaga et al. [8] 
characterized electrophysiologically an L-type like cal­
cium channel present in cultured renal distal convo­
luted tubules. This channel could be blocked by 10 juM 
nifedipine.
Secondly, we have demonstrated that felodipine, like 
verapamil, protects renal tubules against hypoxic injury 
in the absence of extracellular calcium. Lowering of the 
extracellular calcium concentration per se did not 
afford protection, but rather increased hypoxic injury. 
Although these results might suggest that calcium influx 
is not involved in the induction of hypoxic renal injury, 
they do not allow straightforward conclusions. The 
absence of calcium causes marked alterations in cell 
metabolism, as reflected by a decrease in intracellular 
potassium and adenosine 5'-triphosphate (ATP) [30]. 
These changes in cell metabolism could well be respon­
sible for the increased cellular injury occurring under 
hypoxic conditions. Also, in view of the important role 
of calcium in the regulation of cell volume [19], lower­
ing of extracellular calcium could prevent cells from 
regulating their volume after swelling. Therefore, our 
data do not allow us to conclude what sort of damage 
is prevented by felodipine in low calcium media.
A third line of evidence is provided by the results of 
the experiments using the non-calcium blocking 
felodipine derivative H I86/86. H 186/86 is a dihy­
dropyridine analogue which does not possess either cal­
cium antagonistic or vasodilatory properties [5], In our 
model, this analogue protected renal tubules against 
hypoxia-induced damage in the same concentration 
range as felodipine (100 |llM but not 10 (iM).
Finally, the effects of the individual enantiomers of 
felodipine were studied in our model. Normally, (—)- 
isomers have higher affinities for the target molecule 
than do (+)-isomers; for example, ( —)-enantiomers of 
the dihydropyridines isradipine and nimodipine show 
a 10- to 100-fold higher affinity for L-type calcium 
channels than their (+)-counterparts [26]. Our experi­
ments show that both stereoisomers of felodipine are 
equally effective in preventing disruption of tubular 
plasma membrane integrity and in increasing and pre­
serving intracellular potassium levels. The protective 
pathway by which felodipine exerts its action is there­
fore not stereoselective.
Taken together, our data indicate that the CCB 
felodipine protects renal tubules from hypoxic injury 
independently of an effect on calcium entry.
Our data suggest a correlation between protection 
from hypoxic injury and the level of intracellular potas­
sium. When intracellular potassium decreased (in low- 
calcium experiments), tubules became more vulnerable 
to hypoxic injury, whereas compounds that increased 
potassium levels (felodipine or its derivative) protected 
tubules from hypoxia. We tried to mimic the protective 
effect of felodipine by using the potassium channel 
blockers quinine, quinidine and glibenclamide. Both 
quinidine and glibenclamide protected hypoxic tubules 
against membrane injury, as assessed by LDH leakage. 
This finding is in agreement with recent studies by 
Reeves and Shah [21], who reported protection by tetra- 
ethylammonium and glibenclamide against hypoxia- 
induced injury in isolated proximal tubules of the rat.
Since felodipine and HI86/86 protect rat proximal 
tubules against hypoxia and increase intracellular 
potassium levels, and some protection could be 
obtained by the use of the potassium channel blockers 
quinidine and glibenclamide, we propose that felodip­
ine and its derivative exert their protective effect by 
blocking potassium channels, which would preserve 
intracellular potassium levels during the first period of 
hypoxia. Delaying cellular potassium leakage could 
slow sodium and chloride influx, and therefore cell 
swelling, which occurs during hypoxia when ATP is no 
longer available for the Na+-K+-ATPase, Tubules incu­
bated in low-calcium media also exhibit an increased 
loss of intracellular potassium. In this situation felodip­
ine also prevented potassium loss, and attenuated cell 
injury Interactions of CCBs with integral membrane 
proteins such as potassium and sodium channels are 
known to occur and have been described by several 
groups [3, 8, 9, 10, 20, 27]. The drug used in our exper­
iments is very lipophilic and has a high lateral diffusion 
coefficient (as high as that for membrane lipids): 
3.8* lO ^cm ^s” 1 [17]. Felodipine accumulates in mem­
branes [17, 26] and is thought to bind to its receptor 
within the membrane bilayer, illustrating its hydropho­
bic character [17]. Therefore, both direct interactions 
with membrane proteins and indirect interactions via 
disruption of the lipid bilayer structure are likely to 
occur.
In our model ATP-sensitive potassium channels 
could be a target for felodipine. Actively transporting 
cells, such as renal epithelial cells, possess ATP-sensi­
tive potassium channels to allow excessive intracellu­
lar potassium, pumped in by the Na+-K*-ATPases, to 
leave the cell again [12, 21, 28]. This prevents potas­
sium accumulation and maintains a large electrical gra­
dient for sodium entry across the apical membrane [12]. 
ATP-sensitive potassium channels open when ATP 
concentrations drop below 1 mM [7, 21]. Reeves and 
Shah [21] recently showed that hypoxia-induced potas­
sium leakage is not due to a decreased influx caused 
by the cessation of the Na+-K+-pump, but to an 
increased potassium efflux. This efflux could be blocked 
by tetraethylammonium and glibenclamide (a specific 
ATP-sensitive potassium channel blocker) at concen­
trations known to block ATP-sensitive potassium
26
channels in rabbit proximal tubules (inhibitory con­
stant, K\ «  250 jaM) [21, 28], Thus, a blockade of ATP- 
sensitive potassium channels during hypoxia, when 
ATP is depleted within minutes, would lead to preser­
vation of intracellular potassium levels. In our model, 
felodipine and its stereoisomers preserved potassium 
levels during the first 15 min of hypoxia and provided 
almost complete protection. The specific blocker of 
ATP-sensitive potassium channels glibenclamide pro­
vided substantial protection in our experiments in the 
same concentrations as used by Reeves and Shah [21]. 
These results suggest a role for potassium channels in 
hypoxic tubular injury, and might explain the protec­
tive effect o f substances which are capable of interact­
ing with these channels. However, the evidence that 
blockade of potassium efflux is involved in the protec­
tion o f cells against hypoxic injury is rather indirect. 
Most agents caused definite membrane injury when 
used at normoxic conditions, and increased potassium 
efflux. During hypoxia, both damaging and protective 
effects are operative, and the resulting LDH release and 
potassium levels can not be predicted easily. Further 
studies should focus on changes in potassium levels in 
individual tubular cells in relation to cell injury.
In summary, we have shown that felodipine protects 
isolated rat proximal tubules from hypoxia-induced 
injury in a calcium-independent way. Felodipine 
increased potassium levels during both normoxia and 
hypoxia. This latter finding suggests that felodipine and 
its derivative might afford protection against hypoxic 
injury by blocking potassium efflux. We have tried to 
corroborate further the relationship between hypoxic 
cell injury and cellular potassium efflux by studying the 
effects of the potassium channel blockers quinine, 
quinidine and glibenclamide. Only quinidine and espe- 
cially glibenclamide afforded some protection against 
hypoxia-induced membrane injury, and the effects of 
these drugs on intracellular potassium levels were not 
conclusive. The interpretation of the effects of the 
potassium channel blockers is further hampered by the 
deleterious effects of these blockers on proximal tubules 
at normoxic conditions. We have also shown that both 
stereoisomers of felodipine are equally effective in 
reducing LDH leakage in our model. Since the (+)-iso- 
mer lacks vasodilatory and hence hypotensive proper­
ties, further study might reveal better and more effective 
ways to use this isoform of felodipine in patients at risk 
of hypoxic injury of the kidney and most likely other 
organs.
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